Egenskap
Migraine
Migraine is a chronic neurological disorder characterized by episodic attacks of headache and associated symptoms.
Sammendrag
- Også kalt
- Intermittent migraine headaches, Migraine headache, Migraine headaches
- Kroppssystem
- Abnormality of the nervous system
Denne siden som data
Legg til .json etter adressen til siden, eller be om application/json, for å lese den som JSON.
library(jsonlite)
url <- "https://dantelabs.com/traits/migraine.json"
page <- fromJSON(url)
page$trait$nameLes genene knyttet til Migraine, og resten av genomet ditt, med én test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test157 gener knyttet til Migraine
Endringer i disse genene forårsaker sjeldne tilstander der Migraine forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| AMACRalpha-methylacyl-CoA racemase | Alltid | I 2 tilstander |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Alltid | I 1 tilstand |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Alltid | I 4 tilstander |
| CSNK1Dcasein kinase 1 delta | Alltid | I 1 tilstand |
| CTSAcathepsin A | Alltid | I 1 tilstand |
| JPH1junctophilin 1 | Alltid | I 1 tilstand |
| LRRC7leucine rich repeat containing 7 | Alltid | I 1 tilstand |
| NOTCH3notch receptor 3 | Alltid | I 3 tilstander |
| PEX11Bperoxisomal biogenesis factor 11 beta | Alltid | I 1 tilstand |
| RAB3ARAB3A, member RAS oncogene family | Alltid | I 1 tilstand |
| ADA2adenosine deaminase 2 | Svært ofte (80–99 %) | I 1 tilstand |
| APPamyloid beta precursor protein | Svært ofte (80–99 %) | I 2 tilstander |
| C4Acomplement C4A (Chido/Rodgers blood group) | Svært ofte (80–99 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| CLTRNcollectrin, amino acid transport regulator | Svært ofte (80–99 %) | I 1 tilstand |
| COL5A1collagen type V alpha 1 chain | Svært ofte (80–99 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| FASFas cell surface death receptor | Svært ofte (80–99 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Svært ofte (80–99 %) | I 2 tilstander |
| IFNGR1interferon gamma receptor 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Svært ofte (80–99 %) | I 1 tilstand |
| IL12Ainterleukin 12A | Svært ofte (80–99 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Svært ofte (80–99 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Svært ofte (80–99 %) | I 1 tilstand |
| KLRC4killer cell lectin like receptor C4 | Svært ofte (80–99 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Svært ofte (80–99 %) | I 1 tilstand |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Svært ofte (80–99 %) | I 2 tilstander |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Svært ofte (80–99 %) | I 2 tilstander |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Svært ofte (80–99 %) | I 2 tilstander |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Svært ofte (80–99 %) | I 2 tilstander |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Svært ofte (80–99 %) | I 1 tilstand |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Svært ofte (80–99 %) | I 2 tilstander |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Svært ofte (80–99 %) | I 2 tilstander |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Svært ofte (80–99 %) | I 2 tilstander |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Svært ofte (80–99 %) | I 2 tilstander |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Svært ofte (80–99 %) | I 2 tilstander |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Svært ofte (80–99 %) | I 2 tilstander |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Svært ofte (80–99 %) | I 2 tilstander |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Svært ofte (80–99 %) | I 2 tilstander |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Svært ofte (80–99 %) | I 2 tilstander |
Vis 117 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| NLRP3NLR family pyrin domain containing 3 | Svært ofte (80–99 %) | I 1 tilstand |
| SLC6A19solute carrier family 6 member 19 | Svært ofte (80–99 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Svært ofte (80–99 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Svært ofte (80–99 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Svært ofte (80–99 %) | I 1 tilstand |
| ACVRL1activin A receptor like type 1 | Ofte (30–79 %) | I 2 tilstander |
| ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3 | Ofte (30–79 %) | I 1 tilstand |
| ADAMTSL1ADAMTS like 1 | Ofte (30–79 %) | I 1 tilstand |
| AIPAHR interacting HSP90 co-chaperone | Ofte (30–79 %) | I 1 tilstand |
| ALPK1alpha kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| ATMATM serine/threonine kinase | Ofte (30–79 %) | I 1 tilstand |
| BMPR1Abone morphogenetic protein receptor type 1A | Ofte (30–79 %) | I 1 tilstand |
| BRCA2BRCA2 DNA repair associated | Ofte (30–79 %) | I 1 tilstand |
| CALRcalreticulin | Ofte (30–79 %) | I 1 tilstand |
| CHEK2checkpoint kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| CST3cystatin C | Ofte (30–79 %) | I 1 tilstand |
| ENGendoglin | Ofte (30–79 %) | I 2 tilstander |
| EPCAMepithelial cell adhesion molecule | Ofte (30–79 %) | I 1 tilstand |
| GATA2GATA binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| GDF2growth differentiation factor 2 | Ofte (30–79 %) | I 1 tilstand |
| GPR101G protein-coupled receptor 101 | Ofte (30–79 %) | I 1 tilstand |
| GUK1guanylate kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| IL12Binterleukin 12B | Ofte (30–79 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Ofte (30–79 %) | I 1 tilstand |
| MLH1mutL homolog 1 | Ofte (30–79 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Ofte (30–79 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Ofte (30–79 %) | I 1 tilstand |
| MRPL39mitochondrial ribosomal protein L39 | Ofte (30–79 %) | I 1 tilstand |
| MSH2mutS homolog 2 | Ofte (30–79 %) | I 1 tilstand |
| MSH6mutS homolog 6 | Ofte (30–79 %) | I 1 tilstand |
| MUTYHmutY DNA glycosylase | Ofte (30–79 %) | I 1 tilstand |
| MVKmevalonate kinase | Ofte (30–79 %) | I 1 tilstand |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| NF1neurofibromin 1 | Ofte (30–79 %) | I 1 tilstand |
| NPATnuclear protein, coactivator of histone transcription | Ofte (30–79 %) | I 1 tilstand |
| PGK1phosphoglycerate kinase 1 | Ofte (30–79 %) | I 2 tilstander |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| PMS1PMS1 homolog 1, mismatch repair system component | Ofte (30–79 %) | I 1 tilstand |
| PMS2PMS1 homolog 2, mismatch repair system component | Ofte (30–79 %) | I 1 tilstand |
| POLD1DNA polymerase delta 1, catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| POLEDNA polymerase epsilon, catalytic subunit | Ofte (30–79 %) | I 1 tilstand |
| POLGDNA polymerase gamma, catalytic subunit | Ofte (30–79 %) | I 4 tilstander |
| RPS20ribosomal protein S20 | Ofte (30–79 %) | I 1 tilstand |
| SEMA4Asemaphorin 4A | Ofte (30–79 %) | I 1 tilstand |
| SH2B3SH2B adaptor protein 3 | Ofte (30–79 %) | I 1 tilstand |
| SMAD2SMAD family member 2 | Ofte (30–79 %) | I 1 tilstand |
| SMAD3SMAD family member 3 | Ofte (30–79 %) | I 2 tilstander |
| SMAD4SMAD family member 4 | Ofte (30–79 %) | I 1 tilstand |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Ofte (30–79 %) | I 1 tilstand |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Ofte (30–79 %) | I 1 tilstand |
| SPOPspeckle type BTB/POZ protein | Ofte (30–79 %) | I 1 tilstand |
| SQORsulfide quinone oxidoreductase | Ofte (30–79 %) | I 1 tilstand |
| STARD7StAR related lipid transfer domain containing 7 | Ofte (30–79 %) | I 1 tilstand |
| STIM1stromal interaction molecule 1 | Ofte (30–79 %) | I 1 tilstand |
| SUFUSUFU negative regulator of hedgehog signaling | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 1 tilstand |
| TGFBR2transforming growth factor beta receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| TP53tumor protein p53 | Ofte (30–79 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Ofte (30–79 %) | I 2 tilstander |
| ZFTAzinc finger translocation associated | Ofte (30–79 %) | I 1 tilstand |
| ACSF3acyl-CoA synthetase family member 3 | Noen ganger (5–29 %) | I 1 tilstand |
| COPB1coat protein complex I subunit beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CTSHcathepsin H | Noen ganger (5–29 %) | I 1 tilstand |
| FGFR2fibroblast growth factor receptor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| FGFR3fibroblast growth factor receptor 3 | Noen ganger (5–29 %) | I 2 tilstander |
| FRMD5FERM domain containing 5 | Noen ganger (5–29 %) | I 1 tilstand |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Noen ganger (5–29 %) | I 1 tilstand |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Noen ganger (5–29 %) | I 1 tilstand |
| HCRThypocretin neuropeptide precursor | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| JAG1jagged canonical Notch ligand 1 | Noen ganger (5–29 %) | I 1 tilstand |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Noen ganger (5–29 %) | I 1 tilstand |
| KCNJ10potassium inwardly rectifying channel subfamily J member 10 | Noen ganger (5–29 %) | I 1 tilstand |
| MOGmyelin oligodendrocyte glycoprotein | Noen ganger (5–29 %) | I 1 tilstand |
| MYD88MYD88 innate immune signal transduction adaptor | Noen ganger (5–29 %) | I 1 tilstand |
| MYORGmyogenesis regulating glycosidase | Noen ganger (5–29 %) | I 1 tilstand |
| NDPnorrin cystine knot growth factor NDP | Noen ganger (5–29 %) | I 1 tilstand |
| NFIXnuclear factor I X | Noen ganger (5–29 %) | I 1 tilstand |
| P2RY11purinergic receptor P2Y11 | Noen ganger (5–29 %) | I 1 tilstand |
| PDGFBplatelet derived growth factor subunit B | Noen ganger (5–29 %) | I 1 tilstand |
| PDGFRBplatelet derived growth factor receptor beta | Noen ganger (5–29 %) | I 1 tilstand |
| PLAAT3phospholipase A and acyltransferase 3 | Noen ganger (5–29 %) | I 1 tilstand |
| PRORPprotein only RNase P catalytic subunit | Noen ganger (5–29 %) | I 1 tilstand |
| PRRT2proline rich transmembrane protein 2 | Noen ganger (5–29 %) | I 2 tilstander |
| RNASEH1ribonuclease H1 | Noen ganger (5–29 %) | I 1 tilstand |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Noen ganger (5–29 %) | I 2 tilstander |
| SH2B1SH2B adaptor protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SLC1A3solute carrier family 1 member 3 | Noen ganger (5–29 %) | I 2 tilstander |
| SLC2A1solute carrier family 2 member 1 | Noen ganger (5–29 %) | I 2 tilstander |
| SRPX2sushi repeat containing protein X-linked 2 | Noen ganger (5–29 %) | I 1 tilstand |
| TNFRSF1ATNF receptor superfamily member 1A | Noen ganger (5–29 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Noen ganger (5–29 %) | I 1 tilstand |
| TWIST1twist family bHLH transcription factor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| TWNKtwinkle mtDNA helicase | Noen ganger (5–29 %) | I 4 tilstander |
| ZNF365zinc finger protein 365 | Noen ganger (5–29 %) | I 1 tilstand |
| DNM1Ldynamin 1L | Sjelden (1–4%) | I 1 tilstand |
| GP1BAglycoprotein Ib platelet subunit alpha | Sjelden (1–4%) | I 1 tilstand |
| GP1BBglycoprotein Ib platelet subunit beta | Sjelden (1–4%) | I 1 tilstand |
| GP9glycoprotein IX platelet | Sjelden (1–4%) | I 1 tilstand |
| LGI1leucine rich glioma inactivated 1 | Sjelden (1–4%) | I 1 tilstand |
| MICAL1microtubule associated monooxygenase, calponin and LIM domain containing 1 | Sjelden (1–4%) | I 1 tilstand |
| NOP56NOP56 ribonucleoprotein | Sjelden (1–4%) | I 1 tilstand |
| OPA1OPA1 mitochondrial dynamin like GTPase | Sjelden (1–4%) | I 2 tilstander |
| POLG2DNA polymerase gamma 2, accessory subunit | Sjelden (1–4%) | I 1 tilstand |
| PPIBpeptidylprolyl isomerase B | Sjelden (1–4%) | I 1 tilstand |
| RELNreelin | Sjelden (1–4%) | I 1 tilstand |
| SLC25A4solute carrier family 25 member 4 | Sjelden (1–4%) | I 1 tilstand |
| ANO1anoctamin 1 | Ikke registrert | I 1 tilstand |
| COL4A1collagen type IV alpha 1 chain | Ikke registrert | I 1 tilstand |
| HTR1A5-hydroxytryptamine receptor 1A | Ikke registrert | I 1 tilstand |
| MT-CYBmitochondrially encoded cytochrome b | Ikke registrert | I 1 tilstand |
| MT-TCmitochondrially encoded tRNA-Cys (UGU/C) | Ikke registrert | I 1 tilstand |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Ikke registrert | I 1 tilstand |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Ikke registrert | I 1 tilstand |
| MT-TVmitochondrially encoded tRNA-Val (GUN) | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker